Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Hamilton

Showing results (51-60 of 186) with videos related to

Pageof 19
Sort By:
Behavioral Biology|November 1, 1974
Quantitative analysis of ciliary and contractile responses during habituation training in Spirostomum ambiguumT C Hamilton, J M Thompson, E M Eisenstein
British Journal of Pharmacology|January 1, 1976
Prolonged effects of p-chlorophenylalanine on the blood pressure of conscious normotensive and DOCA/saline hypertensive ratsR E Buckingham, T C Hamilton, R A Moore
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 15, 2006
Recent insights into platinum drug resistance in cancerS W Johnson, K V Ferry, T C Hamilton
Progress in Clinical and Biological Research|January 1, 1986
Modulation of drug resistance in human ovarian cancer: experimental results and clinical applicationsR F Ozols, T C Hamilton, R C Young
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
New non-cytotoxic approaches to ovarian cancerS B Kaye, E A Eisenhauer, T C Hamilton
Current Opinion in Oncology|November 1, 1993
Platinum analogues in preclinical and clinical developmentT C Hamilton, P J O'Dwyer, R F Ozols
European Journal of Pharmacology|May 12, 1994
K+ channel activators, acute glucose tolerance and glibenclamide-induced hypoglycaemia in the hypertensive ratJ C Clapham, B K Trail, T C Hamilton
Gynecologic Oncology|July 1, 1992
Potentiation of cisplatin cytotoxicity in human ovarian carcinoma cell lines by trifluoperazine, a calmodulin inhibitorR P Perez, L M Handel, T C Hamilton
Gynecologic Oncology|October 1, 1993
Clinical reversal of drug resistance in ovarian cancerR F Ozols, P J O'Dwyer, T C Hamilton
Biochemical Pharmacology|September 29, 2000
Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPFK V Ferry, T C Hamilton, S W Johnson
Pageof 19

Showing results (51-60 of 186) with videos related to

Sort By:
Pageof 19
Behavioral Biology|November 1, 1974
Quantitative analysis of ciliary and contractile responses during habituation training in Spirostomum ambiguumT C Hamilton, J M Thompson, E M Eisenstein
British Journal of Pharmacology|January 1, 1976
Prolonged effects of p-chlorophenylalanine on the blood pressure of conscious normotensive and DOCA/saline hypertensive ratsR E Buckingham, T C Hamilton, R A Moore
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 15, 2006
Recent insights into platinum drug resistance in cancerS W Johnson, K V Ferry, T C Hamilton
Progress in Clinical and Biological Research|January 1, 1986
Modulation of drug resistance in human ovarian cancer: experimental results and clinical applicationsR F Ozols, T C Hamilton, R C Young
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
New non-cytotoxic approaches to ovarian cancerS B Kaye, E A Eisenhauer, T C Hamilton
Current Opinion in Oncology|November 1, 1993
Platinum analogues in preclinical and clinical developmentT C Hamilton, P J O'Dwyer, R F Ozols
European Journal of Pharmacology|May 12, 1994
K+ channel activators, acute glucose tolerance and glibenclamide-induced hypoglycaemia in the hypertensive ratJ C Clapham, B K Trail, T C Hamilton
Gynecologic Oncology|July 1, 1992
Potentiation of cisplatin cytotoxicity in human ovarian carcinoma cell lines by trifluoperazine, a calmodulin inhibitorR P Perez, L M Handel, T C Hamilton
Gynecologic Oncology|October 1, 1993
Clinical reversal of drug resistance in ovarian cancerR F Ozols, P J O'Dwyer, T C Hamilton
Biochemical Pharmacology|September 29, 2000
Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPFK V Ferry, T C Hamilton, S W Johnson
Pageof 19